Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults
Status:
COMPLETED
Trial end date:
2023-12-05
Target enrollment:
Participant gender:
Summary
This is an open-label, 2-Part, phase 1 study to evaluate drug interactions when DA-8010 is co-administered with Paroxetine or Mirabegron in healthy adult subjects